Severe pruritus of cholestasis in disseminated cancer: Developing a rational treatment strategy. A case report

Journal of Pain and Symptom Management

Volumn 29, Issue 1, 2005, Pages 100-103

  Zylicz, Zbigniew ^a,d   Stork, Neeltje ^b   Krajnik, Małgorzata ^c  

^a Department of Cancer Registry and Research   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c KAZIMIERZ WIELKI UNIVERSITY   (Poland)

^d Section of Epidemiology   (Netherlands)

Author keywords

buprenorphine; cholestasis; itch; naltrexone; Pruritus

Indexed keywords

ACENOCOUMAROL; BUPRENORPHINE; CODEINE; DIAZEPAM; DIGOXIN; FUROSEMIDE; GLIMEPIRIDE; HALOPERIDOL; LACTITOL; LEVOTHYROXINE; LOSARTAN; METOPROLOL; MIDAZOLAM; MIRTAZAPINE; MORPHINE; NALOXONE; NALTREXONE; NIFEDIPINE; PARACETAMOL; PAROXETINE; PROMETHAZINE; TROPISETRON;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHOLESTASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DISSEMINATED CANCER; FECES INCONTINENCE; FEMALE; HUMAN; LOW BACK PAIN; NAUSEA; PHYSICAL EXAMINATION; PRURITUS; SKIN IRRITATION; SWEATING; TREATMENT FAILURE; TREATMENT WITHDRAWAL; VOMITING;

EID: 12344291816     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2004.04.009     Document Type: Short Survey

References (13)

1. R. Terg, E. Coronel, J. Sorda, A.E. Munoz, and J. Findor Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study J Hepatol 37 2002 717 722
2. L.D. Juby, V.S. Wong, and M.S. Losowsky Buprenorphine and hepatic pruritus Br J Clin Pract 48 1994 331
3. M.P. Davis, J.L. Frandsen, D. Walsh, S. Andresen, and S. Taylor Mirtazapine for pruritus J Pain Symptom Manage 25 2003 288 291
4. Z. Zylicz, M. Krajnik, A.A. Sorge, and M. Costantini Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial J Pain Symptom Manage 26 2003 1105 1112
5. C. Muller, S. Pongratz, and J. Pidlich Treatment of pruritus in chronic liver disease with the 5- hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial Eur J Gastroenterol Hepatol 10 1998 865 870
6. J.W. O'Donohue, C. Haigh, and R. Williams Ondansetron in the treatment of pruritus of cholestasis: a randomised controlled trial Gastroenterology 112 1997 A1349
7. E.A. Jones Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions J Hepatol 37 2002 863 865
8. M.G. Swain, R.B. Rothman, and H. Xu Endogenous opioids accumulate in plasma in a rat model of acute cholestasis Gastroenterology 103 1992 630 635
9. N.V. Bergasa, S. Liau, P. Homel, and V. Ghali Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis Liver 22 2002 107 113
10. N.V. Bergasa, D.W. Alling, T.L. Talbot, M.C. Wells, and E.A. Jones Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study J Am Acad Dermatol 41 1999 431 434
11. 1-opioid receptors Life Sci 56 1995 285 290
12. J. Kamei, A. Saitoh, K. Morita, and H. Nagase Antagonistic effect of buprenorphine on the antitussive effect of morphine is mediated via the activation of mu 1-opioid receptors Life Sci 57 1995 PL231 PL235
13. E.A. Jones, J. Neuberger, and N.V. Bergasa Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions QJM 95 2002 547 552